Treatment of functional gut symptoms in patients with quiescent IBD and IBS - a single-blinded parallel trial assessing efficacy of app-delivered gut-directed hypnotherapy versus psycho-education (ACTRN12624000678594)

App-delivered psychological treatment of IBS-in-IBD

This trial is Currently recruiting
Registration number ACTRN12624000678594
This trial will compare the effects of one of two app-delivered psychological programs on persistent gastrointestinal symptoms in people with inflammatory bowel disease in remission and persistent symptoms (termed IBS-in-IBD).

Program & service

This trial is being run with the Specialty Medicine service, and as part of the Gastroenterology program.

Trial phase

Other

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

A/Prof Emma Halmos

Key inclusion data

Inclusion criteria: Patients with IBD in remission or mildly active disease; Gastrointestinal symptoms meeting IBS criteria. Exclusion criteria: New IBS therapies in the prior 4 weeks; Patients unsuitable for intestinal ultrasound.

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.